Targeting Dependency on a Paralog Pair of CBP/p300 against De-repression of KREMEN2 in SMARCB1-Deficient Cancers
ChIP-seq / ATAC-seq (genome binding and open chromatin) · human · 60 samples
- What it is
- ChIP-seq / ATAC-seq (genome binding and open chromatin)Where proteins bind the genome, or which regions are open and active.
- Organism
- Homo sapiens (human)
- Samples
- 60 samples: 59 distinct titles, 1 of them repeatedGroups are read from the sample names, not from the paper. Check the list below.
- Data you can get
- A processed table (series matrix) and supplementary files from NCBI; the raw sequencing reads from ENA. Which of these hold counts depends on the study, so check the file list.
- Paper
- Targeting dependency on a paralog pair of CBP/p300 against de-repression of KREMEN2 in SMARCB1-deficient cancersNature communications · 2024
Read the full summary ↓
Direct links to NCBI and ENA, no account and no request form. Pick by what you want to do: take the small processed table to look, the supplementary files to re-analyse, or the original raw data to start over.
Processed table
The series matrix: one table of values per sample as the submitters processed it. The smallest download, and it opens in Excel or R. Start here to see what the data look like.
Supplementary files
The count tables and other files the authors uploaded. Take only the samples you need, or the whole study as GSE237043_RAW.tar (it can run to tens of gigabytes).
Raw sequencing reads
The original FASTQ files, straight from the sequencer, held at ENA. Large, and you align them yourself, so only choose this if you need to re-process the study from scratch.
What the files usually look like: Look for peak files (.bed, .narrowPeak) and signal tracks (.bigWig) among the supplementary files; the raw reads are on ENA.
Also filed as BioProject PRJNA993628 and SRA study SRP449366. Searching any of these in the dataset finder brings you back here.
How we read this: Read from 60 sample titles: 59 distinct titles with little repetition. These groups are guessed from the sample names, not taken from the paper, so check them against the sample list below before relying on them.
- GSM7593481 RNA_786O_A485_2uM_24h
- GSM7593482 RNA_786O_NT_24h
- GSM7593483 RNA_G402_A485_2uM_24h
- GSM7593484 RNA_G402_NT_24h
- GSM7593485 RNA_HSES2R_A485_2uM_24h
- GSM7593486 RNA_HSES2R_NT_24h
- GSM7593487 RNA_HSES2R_siCBPsip300_96h
- GSM7593488 RNA_HSES2R_siKREMEN2_96h
- GSM7593489 RNA_HSES2R_siNT_96h
- GSM7593490 RNA_JMURTK2_Mock_A485_2uM_24h
- GSM7593491 RNA_JMURTK2_Mock_NT_24h
- GSM7593492 RNA_JMURTK2_Mock_siCBPsip300_96h
- GSM7593493 RNA_JMURTK2_Mock_siKREMEN2_96h
- GSM7593494 RNA_JMURTK2_Mock_siNT_96h
- GSM7593495 RNA_JMURTK2_SMARCB1_A485_2uM_24h
- GSM7593496 RNA_JMURTK2_SMARCB1_NT_24h
- GSM7593497 RNA_NEPS_A485_2uM_24h
- GSM7593498 RNA_NEPS_NT_24h
- GSM7593499 ATAC_JMURTK2_Mock_A2_24h
- GSM7593500 ATAC_JMURTK2_Mock_NT_24h
- GSM7593502 ATAC_JMURTK2_siCBPsip300_48h
- GSM7593503 ATAC_JMURTK2_siNT_48h
- GSM7593504 ATAC_JMURTK2_SMARCB1_NT_24h
- GSM7593505 BRD4_JMURTK2_Mock_A485
- GSM7593506 BRD4_JMURTK2_Mock_NT
- GSM7593507 CTCF_JMURTK2_Mock_A485
- GSM7593508 CTCF_JMURTK2_Mock_NT
- GSM7593509 H3K4me1_JMURTK2_Mock_NT
- GSM7593510 H3K4me1_JMURTK2_SMARCB1_NT
- GSM7593511 H3K4me3_JMURTK2_Mock_NT
- GSM7593512 H3K4me3_JMURTK2_SMARCB1_NT
- GSM7593513 H3K27ac_786O_NT
- GSM7593514 H3K27ac_JMURTK2_Mock_A485
- GSM7593515 H3K27ac_JMURTK2_Mock_NT
- GSM7593516 H3K27ac_JMURTK2_Mock_NT2
- GSM7593517 H3K27ac_JMURTK2_SMARCB1_NT
- GSM7593518 H3K27ac_NEPS_NT
- GSM7593519 H3K27me3_JMURTK2_Mock_NT
- GSM7593520 H3K27me3_JMURTK2_SMARCB1_NT
- GSM7593521 Input_786O_NT
+ 20 more — browse all 60 samples with per-sample file links →
- GSE255134 Targeting histone H2B acetylated enhanceosomes via p300/CBP degradation in prostate cancer 76 samples shares p300, cbp, targeting
- GSE296250 Targeting p300/CBP abolishes HOXB13 loss-induced lipogenesis and tumor metastasis 43 samples shares p300, cbp, targeting
- GSE255132 Targeting histone H2B acetylated enhanceosomes via p300/CBP degradation in prostate cancer (ChIP-Seq) 38 samples shares p300, cbp, targeting
- GSE255133 Targeting histone H2B acetylated enhanceosomes via p300/CBP degradation in prostate cancer (RNA-Seq) 32 samples shares p300, cbp, targeting
- GSE296237 Targeting p300/CBP abolishes HOXB13 loss-induced lipogenesis and tumor metastasis [RNA-seq] 28 samples shares p300, cbp, targeting
- GSE296236 Targeting p300/CBP abolishes HOXB13 loss-induced lipogenesis and tumor metastasis [ChIP-seq] 15 samples shares p300, cbp, targeting
- GSE291279 Therapeutic Targeting of the p300/CBP Bromodomain Enhances the Efficacy of Immune Checkpoint Blockade Therapy 6 samples shares p300, cbp, targeting
- GSE292455 ATF4:p52 Complex Activates Oncogenic Enhancers in Multiple Myeloma via p300/CBP Recruitment to Regulate BACH1 31 samples shares p300, cbp
Metadata from NCBI GEO, cached and refreshed periodically — the NCBI page above is authoritative. Downloads link straight to NCBI/ENA; nothing is proxied through BioTransfer.